Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Altman Z-Score: 38.46 (As of Aug. 20, 2026) — 42% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02291 Lepu Scientech Medical Technology (Shanghai) Co Ltd HKSE:02291
76 GF Score
Price HK$12.18
GF Value HK$44.29
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Lepu Scientech Medical Technology (Shanghai) Co Altman Z-Score?

Lepu Scientech Medical Technology (Shanghai) Co HKSE:02291 +6.75% 76 Altman Z-Score is 38.46 as of Aug. 20, 2026, which is 42% below its 10-year median of 66.63. GuruFocus rates HKSE:02291 with a GF Score™ of 76/100 and a GF Value™ of HK$44.29 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 806 Medical Devices & Instruments companies, Lepu Scientech Medical Technology (Shanghai) Co ranks better than 97.15% on this metric.

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 34.99 is strong.

Lepu Scientech Medical Technology (Shanghai) Co has a Altman Z-Score of 38.46, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Lepu Scientech Medical Technology (Shanghai) Co's Altman Z-Score or its related term are showing as below:

HKSE:02291' s Altman Z-Score Range Over the Past 10 Years
Min: 34.99   Med: 66.63   Max: 87.42
Current: 34.99

During the past 7 years, Lepu Scientech Medical Technology (Shanghai) Co's highest Altman Z-Score was 87.42. The lowest was 34.99. And the median was 66.63.


Lepu Scientech Medical Technology (Shanghai) Co  (HKSE:02291) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Lepu Scientech Medical Technology (Shanghai) Co Altman Z-Score Related Terms


Lepu Scientech Medical Technology (Shanghai) Co Altman Z-Score Historical Data

* Premium members only.

The historical data trend for Lepu Scientech Medical Technology (Shanghai) Co's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lepu Scientech Medical Technology (Shanghai) Co Altman Z-Score Chart

Lepu Scientech Medical Technology (Shanghai) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z-Score
Get a 7-Day Free Trial 0.00 83.08 87.42 41.14 50.17

Lepu Scientech Medical Technology (Shanghai) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.42 0.00 41.14 0.00 50.17

HKSE:02291 vs ABT, SYK, MDT: Altman Z-Score Comparison

For the Medical Devices subindustry, Lepu Scientech Medical Technology (Shanghai) Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lepu Scientech Medical Technology (Shanghai) Co Altman Z-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lepu Scientech Medical Technology (Shanghai) Co's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Lepu Scientech Medical Technology (Shanghai) Co's Altman Z-Score falls into.


HKSE:02291
76GF Score
Lepu Scientech Medical Technology (Shanghai) Co Ltd HKSE:02291
Altman Z-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lepu Scientech Medical Technology (Shanghai) Co Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Lepu Scientech Medical Technology (Shanghai) Co's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.6516+1.4*0.1429+3.3*0.1318+0.6*61.3215+1.0*0.2515
=38.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was HK$2,318.7 Mil.
Total Current Assets was HK$1,577.9 Mil.
Total Current Liabilities was HK$67.0 Mil.
Retained Earnings was HK$331.3 Mil.
Pre-Tax Income was HK$305.4 Mil.
Interest Expense was HK$-0.1 Mil.
Revenue was HK$583.2 Mil.
Market Cap (Today) was HK$4,198.4 Mil.
Total Liabilities was HK$68.5 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(1577.891 - 67.029)/2318.736
=0.6516

X2=Retained Earnings/Total Assets
=331.321/2318.736
=0.1429

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(305.416 - -0.129)/2318.736
=0.1318

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=4198.374/68.465
=61.3215

X5=Revenue/Total Assets
=583.233/2318.736
=0.2515

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Lepu Scientech Medical Technology (Shanghai) Co has a Altman Z-Score of 38.46 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.

Frequently Asked Questions Learn more about Altman Z-Score →
What does a Altman Z-Score of 38.46 mean?
Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) has a Altman Z-Score of 38.46 as of Aug. 20, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Lepu Scientech Medical Technology (Shanghai) Co and its competitors. This is 42% below median its historical median of 66.63. Over the past decade, Lepu Scientech Medical Technology (Shanghai) Co's Altman Z-Score has ranged from 34.99 to 87.42. According to the industry distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #23 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 2.9%.
Is Lepu Scientech Medical Technology (Shanghai) Co's Altman Z-Score too high?
Lepu Scientech Medical Technology (Shanghai) Co's current Altman Z-Score of 38.46 is 42% below median its 10-year median of 66.63. Over the past 10 years, this metric has ranged from a low of 34.99 to a high of 87.42. The Medical Devices & Instruments industry median Altman Z-Score is 3.12. Lepu Scientech Medical Technology (Shanghai) Co's value of 38.46 is 1134.7% above this industry median. Based on the distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #23 out of 806 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Lepu Scientech Medical Technology (Shanghai) Co has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lepu Scientech Medical Technology (Shanghai) Co's Altman Z-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #23 out of 806 companies for Altman Z-Score. This places Lepu Scientech Medical Technology (Shanghai) Co in the top 3% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 3.12. Lepu Scientech Medical Technology (Shanghai) Co's value of 38.46 is 1134.7% above this benchmark. Historically, Lepu Scientech Medical Technology (Shanghai) Co's own Altman Z-Score has ranged from 34.99 to 87.42 over the past decade. While the company's 10-year median is 66.63 vs. the industry median of 3.12, Lepu Scientech Medical Technology (Shanghai) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Devices & Instruments company?
The median Altman Z-Score among Medical Devices & Instruments companies is 3.12, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lepu Scientech Medical Technology (Shanghai) Co's current Altman Z-Score of 38.46 is 1134.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Lepu Scientech Medical Technology (Shanghai) Co and its competitors. For the Medical Devices & Instruments industry, the median Altman Z-Score is 3.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lepu Scientech Medical Technology (Shanghai) Co's current Altman Z-Score is 38.46, which is 42% below median its own 10-year median of 66.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lepu Scientech Medical Technology (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$44.29, compared to a current price of HK$12.18 — trading 72.5% below its estimated fair value. The current Altman Z-Score is 38.46, which is 42% below median its 10-year median of 66.63 and 1134.7% above the Medical Devices & Instruments industry median of 3.12. Lepu Scientech Medical Technology (Shanghai) Co's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291), the current Altman Z-Score is 38.46 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Overvalued in 2026?

Based on GuruFocus' analysis, Lepu Scientech Medical Technology (Shanghai) Co stock appears to be undervalued. The current stock price of HK$12.18 is trading 72.5% below its estimated GF Value™ of HK$44.29. GuruFocus considers Lepu Scientech Medical Technology (Shanghai) Co to be Significantly Undervalued.

Key valuation signals for HKSE:02291:

  • Altman Z-Score: 38.46 (42% below median its 10-year median of 66.63)
  • GF Value™: HK$44.29 vs. price of HK$12.18 (72.5% below fair value)
  • GF Score™: 76/100 with 1 warning sign
  • Industry Position: 1134.7% above the Medical Devices & Instruments median (#23 of 806)

No single metric tells the full story. See the HKSE:02291 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lepu Scientech Medical Technology (Shanghai) Co Business Description

Address No. 258, Xinzhuan Road, 1st Floor, 5th Floor Building 41, Songjiang District, Shanghai, CHN, 201612
Lepu Scientech Medical Technology (Shanghai) Co Ltd is focused on the research and development, manufacture, and commercialization of heart disease interventional medical devices. The reporting segments of the Group are as follows: The Occluder business segment and The heart valve business segment. The company generates majority of its revenue from the Occluder segment which is engaged in the research and development, manufacturing and sales of interventional treatment series occluders for the defective congenital heart disease.
76GF Score

Get the complete analysis for HKSE:02291

Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$12.18
Price
HK$44.29
GF Value